We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
  DARWIN EU completes its first studies and is calling for new data partners,   March 30, 2023
  Transcenta’s Osemitamab targeting Claudin18.2 gets US FDA orphan drug designation to treat pancreatic cancer,   March 30, 2023
  US FDA approves Emergent BioSolutions’ OTC naloxone nasal spray,   March 30, 2023
  Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth,   March 30, 2023
  Bristol Myers gets European approval for Sotyktu to treat adults with moderate-to-severe plaque psoriasis,   March 30, 2023
  Supply chain, continuous manufacturing pose challenge for US CDMOs,   March 30, 2023
  IOnctura awarded UK’s MHRA Innovation Passport for entry into Innovative Licensing and Access Pathway,   March 29, 2023
  Vifor Fresenius Medical announces Tavneos included in updated EULAR recommendations for management of AAV,   March 29, 2023
  Incyte’s Pemazyre receives Japanese approval to treat patients with myeloid/lymphoid neoplasms,   March 28, 2023
  Daiichi Sankyo’s Enhertu receives Japanese approval to treat patients with HER2 low metastatic breast cancer,   March 28, 2023
  US FDA accepts Delcath Systems’NDA resubmission of Hepzato Kit,   March 28, 2023
  BrainStorm Cell Therapeutics announces US FDA committee to review BLA for NurOwn to treat amyotrophic lateral sclerosis,   March 28, 2023
  US FDA issues complete response letter to Incyte’s ruxolitinib XR tablets,   March 27, 2023
  Iovance completes BLA submission to US FDA for lifileucel in advanced melanoma,   March 27, 2023
  US FDA approves Pharming’s Joenja to treat APDS in adult and paediatric patients 12 years of age and older,   March 27, 2023
  US FDA approves Cidara & Melinta’s Rezzayo to treat candidemia and invasive candidiasis,   March 25, 2023
  Creative Medical seeks US FDA orphan drug designation for ImmCelz platform to treat brittle type 1 diabetes,   March 25, 2023
  Japan’s PMDA approves Aurion Biotech’s novel cell therapy, Vyznova to treat corneal endothelial disease,   March 25, 2023
  Chugai’s Enspryng gets forerunner designation from MHLW of Japan to treat MOGAD and autoimmune encephalitis,   March 25, 2023
  US FDA advisory committee voted unanimously for potential accelerated approval for Ionis’ tofersen for SOD1-ALS,   March 24, 2023

India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |